Home > Press > All Star Analysts Portfolio highlights: AMETEK, Cephalon, Helix Energy Solutions and Marriott Int’l
Zacks.com just released its latest additions and deletions to its proprietary All Star Analyst portfolio. Members on this exclusive list include AMETEK, Inc. (NYSE: AME), Cephalon, Inc. (NASDAQ: CEPH), Helix Energy Solutions (NYSE: HLX) and Marriott International, Inc. (NYSE: MAR). View the entire list of stocks on the All Star Analyst portfolio at http://at.zacks.com/?id=510
All Star Analysts Portfolio highlights: AMETEK, Cephalon, Helix Energy Solutions and Marriott Int’l
Chicago, IL | Posted on August 17th, 2007
This exclusive portfolio represents all stocks with a Strong Buy rating from at least four analysts with a 5-Star All Star ranking. These are the brokerage analysts whose stock recommendations proved to be the most profitable for investors. Since July 2002, this portfolio has generated an annualized return of 7.53%. Here is a synopsis of why these stocks are in the All Star Analysts Portfolio:
AMETEK, Inc. (NYSE: AME) announced earlier this week that it acquired CAMECA SAS from an investment group led by the Carlyle Group for approximately $112 million. CAMECA SAS is a French manufacturer of high-end elemental analysis systems used in advanced lab research, semiconductor and nanotechnology applications. According to AMETEK, the acquisition significantly broadens its technical capabilities in differentiated, high-end analytical instrumentation. AMETEK remains a member of the All Star Analyst Portfolio. For its second quarter, the company posted earnings per share of 54 cents on sales of $519.5 million, compared to the previous year's 43 cents on $450.6 million. The earnings result bettered the consensus by 3.9% while sales growth was 15%.
Cephalon, Inc. (NASDAQ: CEPH) recently announced positive results for a trial of FENTORA® in the treatment of breakthrough pain associated with a broad range of chronic, non-cancer pain conditions. The drug has already been approved to treat pain in cancer patients. The company plans to submit the data to the FDA in the fourth quarter as part of its supplemental New Drug Application. The study was a double-blind, placebo-controlled, variable dose Phase 3 trial, which included 148 patients. Cephalon is an international biopharmaceutical company with a focus on four core therapeutic areas: central nervous system, pain, oncology and addiction. It remains a member of the All Star Analyst Portfolio.
Helix Energy Solutions (NYSE: HLX) is an international offshore energy company that provides development solutions and other key life of field services to the open energy market as well as to its own oil and gas business unit. The company's second quarter was challenging, but it was able to put together some solid numbers. Earnings per share of 70 cents moved past the consensus by almost 8% while revenues advanced by $105.6 million to $410.6 million. Revenue growth was driven primarily by an increase in oil and gas sales of $61 million, thanks mainly to the production added from the acquisition of Remington Oil & Gas.
Marriott International, Inc. (NYSE: MAR) recently announced that its Board approved an increase in its stock repurchase authorization by 40 million shares, bringing the total purchase authorization to approximately 51 million shares. At the same time, the lodging giant declared a quarterly cash dividend of 7.50 cents per share of common stock, payable Oct 23 to shareholders of record as of Sep 6. The company has paid a dividend in every quarter since late 1977. Marriott International remains one of the All Stars' favorite names in its industry.
Discover all the current All Star Analyst rankings and top analyst recommendations at http://at.zacks.com/?id=511
About Zacks All Star Analyst Survey
To learn which brokerage analysts are the best in their field and what stocks they're recommending today, see the Zacks All Star Analyst survey. This exclusive survey, created with Fortune Magazine, reveals the "Best-of-Breed" brokerage analysts. They are the select group of winners from the universe of brokerage analysts - the ones who consistently beat the street - the few you should be following now. Visit the Zacks All Star Survey to find the best analysts and their top stock recommendations at http://at.zacks.com/?id=512
Top recommendations from All Star Analysts Highlighted in FREE Investment Newsletter
Each week, Zacks.com highlights investment insight and favorite recommendations from All Star Analysts and other leading investment experts. This is all part of our FREE e-mail newsletter, "Profit from the Pros." The only way to get these powerful insights is with a FREE subscription to the "Profit from the Pros" investment newsletter. Register for a free subscription at http://at.zacks.com/?id=513
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros http://at.zacks.com/?id=514
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
*The S&P 500 Index is a well-known, unmanaged index of the prices of 500 large-company common stocks, mainly blue-chip stocks, selected by Standard & Poor's. The S&P 500 Index assumes reinvestment of dividends but does not reflect advisory fees. An investor cannot invest directly in an index.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
For more information, please click here
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Arrowhead Issues Open Letter to Shareholders October 9th, 2014
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014
Imaging electric charge propagating along microbial nanowires October 20th, 2014
Superconducting circuits, simplified: New circuit design could unlock the power of experimental superconducting computer chips October 18th, 2014
3DXNano™ ESD Carbon Nanotube 3D Printing Filament - optimized for demanding 3D printing applications in the semi-con and electronics industry October 16th, 2014
Imaging electric charge propagating along microbial nanowires October 20th, 2014
Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014
Physicists build reversible laser tractor beam October 20th, 2014
Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014
New Grand ARM Transmission Electron Microscope Offers Highest Commercially-Available Atomic Resolution of 63 Picometers October 17th, 2014
Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014
Nanotronics Imaging Releases nSPEC® 3D, Powerful Microscope That Captures 3D Images at Nanoscale, in Lightning Speed: Company Unveils Design at American Chemical Society 2014 International Elastomer Conference October 14th, 2014
Unique catalysts for hydrogen fuel cells synthesized in ordinary kitchen microwave oven October 14th, 2014